Evidence map›Paper›PMID 22911866›Full record

ArticlePloS one2012

N-terminally glutamate-substituted analogue of gramicidin A as protonophore and selective mitochondrial uncoupler.

Alexandra I Sorochkina, Egor Y Plotnikov, Tatyana I Rokitskaya, Sergei I Kovalchuk, Elena A Kotova, Sergei V Sychev, Dmitry B Zorov, Yuri N Antonenko

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Kupyaphores─Self-Assembling Diisocyanolipopeptide ZnJournal of the American Chemical Society · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Design, synthesis, and biological evaluation of stable βEuropean journal of medicinal chemistry · 2018
    Article
  6. Article
  7. Gramicidin A: A New Mission for an Old Antibiotic.Journal of kidney cancer and VHL · 2015
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Alexandra I SorochkinaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Egor Y Plotnikov
Tatyana I Rokitskaya
Sergei I Kovalchuk
Elena A Kotova
Sergei V Sychev
Dmitry B Zorov
Yuri N Antonenko
Lomonosov Moscow State University · RUInstitute of Bioorganic Chemistry · RURussian Academy of Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Limited uncoupling of oxidative phosphorylation could be beneficial for cells by preventing excessive generation of reactive oxygen species. Typical uncouplers are weak organic acids capable of permeating across membranes with a narrow gap between efficacy and toxicity. Aimed at designing a nontoxic uncoupler, the protonatable amino acid residue Glu was substituted for Val at the N-terminus of the pentadecapeptide gramicidin A (gA). The modified peptide [Glu1]gA exhibited high uncoupling activity in isolated mitochondria, in particular, abolishing membrane potential at the inner mitochondrial membrane with the same or even larger efficacy as gA. With mitochondria in cell culture, the depolarizing activity of [Glu1]gA was observed at concentrations by an order of magnitude lower than those of gA. On the contrary, [Glu1]gA was much less potent in forming proton channels in planar lipid bilayers than gA. Remarkably, at uncoupling concentrations, [Glu1]gA did not alter cell morphology and was nontoxic in MTT test, in contrast to gA showing high toxicity. The difference in the behavior of [Glu1]gA and gA in natural and artificial membranes could be ascribed to increased capability of [Glu1]gA to permeate through membranes and/or redistribute between different membranes. Based on the protective role of mild uncoupling, [Glu1]gA and some other proton-conducting gA analogues may be considered as prototypes of prospective therapeutic agents.

Indexed as

Amino Acid SubstitutionAmino Acid SequenceAnimalsCells, CulturedCell SurvivalElectricityGlutamic AcidGramicidinHydrogen-Ion ConcentrationIon ChannelsKidneyLipid BilayersLiposomesMaleMembrane Potential, MitochondrialMitochondria, LiverGlutamic AcidGramicidinIon ChannelsLipid BilayersLiposomesPeptidesPhenazinesProton Ionophoressafranine TUncoupling Agents

Identifiers

PMID22911866
PMCPMC3404012
OpenAlexW1994379568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.